Starting a pharmaceutical manufacturing unit in India requires considerable planning, technical expertise, regulatory compliance and investment.

A pharmaceutical project should not begin simply by purchasing a tablet machine, syrup vessel or capsule filler.

The correct sequence is:

Product Selection → Regulatory Classification → Capacity Planning → Plant Layout → Utilities → Machinery → Quality Control → Manpower → Validation → Licensing → Commercial Production

A modern pharmaceutical manufacturing plant must comply not only with manufacturing-licence conditions but also with the revised Schedule M requirements for Good Manufacturing Practices, premises, plant and equipment.

India’s revised Schedule M was notified through G.S.R. 922(E) dated December 28, 2023. It requires manufacturers to establish a Pharmaceutical Quality System incorporating GMP and Quality Risk Management and to provide suitable personnel, premises, equipment and facilities throughout the product lifecycle.

Quick Answer

To start a pharmaceutical manufacturing unit, you generally need:

1. Appropriate business entity
2. Industrial premises
3. Approved pharmaceutical plant layout
4. Applicable drug manufacturing licence
5. Revised Schedule M-compliant facility
6. Production machinery
7. HVAC and utility systems
8. Pharmaceutical water system
9. Quality Control laboratory
10. Quality Assurance department
11. Qualified technical staff
12. Equipment qualification
13. Process and cleaning validation
14. Product permissions
15. Raw-material and packaging suppliers
16. Working capital
17. Marketing or contract-manufacturing customers

The machinery and area required depend entirely on the dosage forms you intend to manufacture.

Which Pharmaceutical Sections Can You Start?

A pharmaceutical manufacturing plant may contain one or more sections such as:

• External preparations
• Oral liquids
• Tablets
• Capsules
• Powders
• Dry syrups
• Ophthalmic preparations
• Parenteral preparations
• Inhalers
• Suppositories and pessaries
• Surgical dressings
• Drug repacking

A first-time entrepreneur should not automatically start every section.

Every additional dosage form increase:

• Civil work
• HVAC
• Machinery
• Validation
• Staff
• Laboratory requirements
• Documentation
• Working capital
• Inspection complexity

For many new manufacturers, beginning with selected non-sterile dosage forms is more manageable than immediately starting injectables or sterile ophthalmics.

Business Models for a Pharmaceutical Factory

Before selecting machinery, decide where your sales will come from.

1. Own Brand Manufacturing

You manufacture and market your own brands through:

• Medical representatives
• PCD franchise
• Stockists
• Distributors
• Hospitals

This requires a separate marketing and distribution budget.

2. Third-Party Manufacturing

You manufacture products for other pharmaceutical marketing companies.

Revenue depends on:

• Manufacturing rate
• Batch size
• Machine utilisation
• Packaging
• Customer credit
• Product development
• Testing

This can be particularly useful for improving plant utilisation.

3. Contract Manufacturing

Large pharma companies may outsource products under:

• Quality agreement
• Technical agreement
• Approved specifications
• Manufacturing agreement

Revised Schedule M requires outsourced activities to be appropriately defined and controlled within the pharmaceutical quality system.

4. Export Manufacturing

An export-oriented unit may manufacture for:

• Overseas distributors
• Contract customers
• Tender markets
• Registered foreign products

This may eventually require:

• WHO-GMP certification
• CoPP
• Country-specific GMP audits
• Dossier support
• Export NOCs where applicable

Step 1: Decide Your Dosage Forms

This is the most important investment decision.

For example, if you select:

Tablets + Capsules

you may share certain upstream equipment such as:

• Sifter
• Blender
• Material handling

but the final manufacturing operations remain different.

If you select:

Liquids + External Preparations

some utility systems may be common, but production areas and processing requirements need appropriate separation.

Machinery should never be shared simply to save money where doing so creates an unacceptable cross-contamination risk.

Revised Schedule M requires equipment and facility design to minimise contamination and cross-contamination and specifies dedicated/self-contained facilities for certain highly sensitising and high-risk products.

Can One Machine Be Used for More Than One Product?

Possibly, but only where:

• Equipment is technically suitable.
• Cross-contamination risk is acceptable.
• Cleaning procedures are validated.
• Product changeover is controlled.
• Batch records identify equipment used.
• No regulatory requirement requires dedicated equipment.

For certain high-risk products, separate facilities may be necessary.

Schedule M specifically identifies products such as certain:

• Penicillins
• Cytotoxics
• Sex hormones
• Live vaccines
• Biological preparations

for dedicated/self-contained or specially controlled manufacturing arrangements.

Step 2: Select Location

The plant should preferably be in an approved industrial location.

Consider:

• Land cost
• Building cost
• Water
• Electricity
• Road connectivity
• Transport
• Skilled manpower
• Raw-material suppliers
• Packaging suppliers
• Pollution-control requirements
• Fire access
• Drainage
• Future expansion

A cheap remote location may eventually become expensive if qualified chemists, engineers and machine operators are difficult to recruit.

Worker and Factory Regulation

Worker health and factory safety also need to be included in the project.

The Occupational Safety, Health and Working Conditions Code, 2020 came into force on November 21, 2025 and now provides the central framework covering occupational safety, working conditions, welfare and factory-related requirements, subject to applicable rules and transition provisions.

Therefore, a 2026 project should not rely only on old references to the Factories Act, 1948.

Step 3: Plant Layout

The layout should follow logical material and personnel flow.

A basic material flow can be:

Material Receipt

↓

Quarantine

↓

Sampling

↓

QC Approval

↓

Approved Raw-Material Store

↓

Dispensing

↓

Manufacturing

↓

Primary Packaging

↓

Secondary Packaging

↓

Finished-Goods Quarantine

↓

QA Release

↓

Finished-Goods Store

↓

Dispatch

Schedule M requires production areas to be logically arranged to minimise confusion, errors and cross-contamination. QC laboratories must also be separated from production areas.

Major Areas Required

A complete plant normally needs significantly more space than the manufacturing-room areas listed in Schedule M.

You may need:

• Raw-material receiving
• Quarantine
• Sampling
• Approved raw-material storage
• Rejected-material area
• Dispensing
• Manufacturing
• Primary packing
• Secondary packing
• Packaging-material store
• Printed packaging store
• Finished-goods quarantine
• Released finished goods
• Returned-goods area
• Recalled-goods area
• QC laboratory
• Microbiology laboratory
• Stability section
• QA office
• Documentation/archive
• Engineering
• Utilities
• Change rooms
• Wash areas
• Corridors
• Airlocks

Therefore, the Schedule M area stated for a manufacturing section should not be interpreted as total factory area.

Recommended Areas Under Revised Schedule M

Schedule M Part XIII uses the word recommended for the following basic installation areas.

Section	Basic Installation	Ancillary
External preparations	30 m²	10 m²
Oral liquids	30 m²	10 m²
Uncoated tablets	60 m²	20 m²
Tablet coating	Additional 30 m²	10 m²
Powders	30 m²	Additional blending room where required
Capsules	25 m²	10 m²
Surgical dressing	30 m²	Additional 30 m² for medicated dressing
Ophthalmics	25 m²	10 m²
Suppositories/Pessaries	20 m²	—
Inhalers/Vitrallae	20 m²	—
Drug repacking	30 m²	—
SVP injections	150 m²	100 m²
LVP in glass containers	150 m²	150 m²

Large-volume parenterals produced through Form-Fill-Seal technology in plastic containers have separate requirements; revised Schedule M recommends 250 m² basic installation plus 150 m² ancillary area.

These figures should be treated as section-specific planning guidance. A GMP architect should calculate the complete built-up area after adding all support functions.

1. External Preparation Section

This section can manufacture products such as:

• Ointments
• Creams
• Lotions
• Pastes
• Topical solutions
• Emulsions
• Dusting powders

Schedule M recommends the following equipment where applicable:

• Mixing and storage tanks
• Jacketed kettle
• Electrically operated mixer
• Planetary mixer
• Colloid mill or emulsifier
• Triple roller mill or ointment mill
• Liquid filling machine
• Jar or tube filling machine

The recommended basic installation area is 30 m² plus 10 m² ancillary area.

Additional Modern Requirements

Budget should also consider:

• HVAC
• Local exhaust
• SS product-transfer system
• Homogenizer
• Vacuum emulsifier, where required
• Tube crimping/sealing
• Coding
• In-process weighing
• Cleaning facilities

Revised Schedule M specifically requires filtered, air-conditioned air/HVAC and suitable exhaust in topical manufacturing areas.

2. Oral Liquid/Syrup Section

Products may include:

• Syrups
• Oral solutions
• Suspensions
• Emulsions
• Elixirs

Recommended equipment includes:

• Stainless-steel mixing/storage tanks
• Jacketed kettle
• Portable stirrer
• Colloid mill or emulsifier
• Filtration equipment
• Bottle filling machine
• Pilfer-proof cap sealing equipment
• Water-processing equipment
• Clarity inspection units

Schedule M recommends 30 m² for basic installation plus 10 m² ancillary area.

Pharmaceutical Water

Revised Schedule M requires the chemical and microbiological quality of Purified Water to be specified and routinely monitored and requires written procedures for operation and maintenance of the Purified Water system.

A modern water system may include, according to source water and design:

• Pretreatment
• Softener
• RO
• EDI where used
• UV
• Storage
• Recirculating loop
• Sanitization system

3. Tablet Manufacturing Section

Tablet manufacturing should be divided into:

1. Mixing/granulation/drying
2. Compression
3. Packaging
4. Coating, where applicable

Schedule M requires dust-control arrangements and recommends isolation of tablet compression machines into cubicles connected to suitable dust extraction.

Granulation and Drying Machinery

Recommended equipment includes:

• Disintegrator
• Sifter
• Powder mixer
• Mass mixer
• Planetary mixer or Rapid Mixer Granulator
• Granulator
• Hot air oven or Fluid Bed Dryer
• Weighing machines

Modern plants commonly select the RMG + FBD route for wet granulation where appropriate.

Compression Equipment

• Tablet compression machine
• Punch and die cabinets
• Tablet deduster
• Tablet inspection unit/belt
• In-process balance
• Hardness tester
• Friability tester
• Disintegration apparatus
• Dissolution apparatus, where applicable
• Environmental controls

Schedule M lists these in its recommended tablet equipment.

Packing Equipment

• Blister packing machine
• Strip packing machine
• Leak-test apparatus
• Tablet counter
• Batch coding
• Cartoning
• Checkweigher, where appropriate

Area

Uncoated tablets:

60 m² basic + 20 m² ancillary

Coating:

Additional 30 m² basic + 10 m² ancillary.

Tablet Coating Machinery

Where coated tablets are manufactured, equipment may include:

• Jacketed kettle for coating solution
• Coating pan
• Automatic perforated coating machine
• Polishing pan where needed
• Exhaust system
• Dust collector
• Air-conditioning
• Dehumidification

An automatic coating system may be commercially preferable to conventional coating pans for larger operations, but the final choice depends on batch size.

4. Capsule Manufacturing Section

Hard-capsule manufacturing should be carried out in a separate enclosed, suitably air-conditioned and dehumidified area with airlock arrangements.

Recommended machinery includes:

• Mixing and blending equipment
• Capsule filling machine
• Capsule counters
• Weighing machine
• Disintegration apparatus
• Capsule polishing machine

Modern projects may also use:

• Capsule deduster/polisher
• Metal detector
• Empty capsule loader
• Automatic capsule inspection
• Blister packing

Area

Schedule M recommends:

25 m² basic installation + 10 m² ancillary area.

5. Powder Section

Products may include applicable:

• Oral powders
• Sachet powders
• Medicated powders

Recommended machinery:

• Disintegrator
• Mixer
• Sifter
• Stainless-steel containers
• Scoops
• Filling machine
• Weighing machine

A dust extraction system is required where fine floating powder is generated.

The recommended area is:

30 m² for basic installation, with an additional room where actual blending is conducted.

6. Surgical Dressing Section

For applicable surgical dressings other than absorbent cotton wool, recommended equipment includes:

• Rolling machine
• Trimming machine
• Cutting equipment
• Gauze folding/pressing machine
• Processing tanks for medicated dressing
• Hot-air oven
• Steam/dry-heat sterilizer where applicable
• Work tables

Schedule M recommends:

30 m² basic installation

and where medicated dressings are produced:

an additional 30 m² room.

7. Ophthalmic Manufacturing Section

Ophthalmic manufacturing should not be treated as an ordinary liquid section.

It is a sterile manufacturing operation requiring appropriate aseptic controls.

Schedule M recommends machinery such as:

• Hot-air oven
• Jacketed kettle
• SS mixing and storage tanks
• Planetary mixer
• Colloid/ointment mill
• Tube filling and crimping
• Tube cleaning
• Vial washing
• Vial drying oven
• Rubber closure washing
• Cartridge/membrane filtration
• Liquid filling
• Autoclave
• Air-conditioning/dehumidification
• Laminar airflow units

The Part XIII recommended basic area is:

25 m² + 10 m² ancillary.

However, that figure alone does not describe the complete sterile facility.

Sterile ophthalmic manufacture must also comply with the specific sterile-product requirements in Part II of revised Schedule M.

8. Suppositories and Pessaries

Recommended machinery includes:

• Mixing equipment
• Pouring equipment
• Moulding equipment
• Weighing equipment

Recommended basic installation area:

20 m².

Where pessaries are produced through granulation and compression, applicable tablet-manufacturing requirements also become relevant.

9. Inhaler Section

Schedule M Part XIII recommends:

• Mixing equipment
• Graduated delivery equipment for measurement during filling
• Sealing equipment

Recommended basic installation area:

20 m².

However, a modern metered-dose inhaler project can be significantly more complex than this short equipment list suggests because it may involve:

• Propellants
• Pressure filling
• Explosion/fire controls
• Specialized HVAC
• Leak testing
• Dose-delivery testing

Therefore, detailed engineering should be based on the specific inhaler technology.

10. Drug Repacking Section

For repacking drugs and pharmaceutical chemicals, revised Schedule M recommends:

• Powder disintegrator
• Powder sifter
• Stainless-steel scoops/vessels
• Weighing and measuring equipment
• Filling machine
• Electric sealing machine

The current recommended basic installation area is 30 m².

11. Parenteral/Injection Manufacturing Section

Parenteral manufacturing requires significantly higher investment and technical expertise.

Schedule M separates the operation into areas including:

• Water management
• Container/closure preparation
• Solution preparation
• Filling/capping/sealing
• Sterilisation
• Quarantine
• Visual inspection
• Packaging

Water Management Equipment

Recommended equipment includes:

• RO or EDI treatment unit
• Multi-column distillation
• Controlled water-storage tank
• Transfer pumps
• Continuously circulating piping

For the parenteral water system described in Schedule M Part XIII, the storage tank and circulating pipeline material is specified as SS-316L.

Container Preparation

• Ampoule/vial/bottle washing machine
• Closure washing
• Dryer/sterilizer
• Dustproof storage
• Stainless-steel benches

Solution Preparation

• SS preparation tanks
• Stirrer
• Cartridge/membrane filters
• Transfer pumps

Filling

• Automatic ampoule/vial filling and sealing
• Laminar airflow
• Gas lines where required

Sterilization

• Steam sterilizer
• Hot-air sterilizer
• Leak-test equipment

Visual Inspection

• Illuminated inspection unit
• Conveyor system

Packaging

• Batch coder
• Labeling machine
• Packing line

Recommended Areas

Small-Volume Injectables

150 m² basic + 100 m² ancillary

Large-Volume Parenterals in Glass

150 m² basic + 150 m² ancillary

Sterile projects also require extensive:

• Classified cleanrooms
• HVAC
• WFI
• Environmental monitoring
• Sterility assurance
• Media fills
• Sterilization validation
• Microbiology

For a first-time small entrepreneur, injectables should normally be treated as a separate high-investment project rather than as one extra room added to a tablet plant.

Quality Control Laboratory

Manufacturing machinery is only half of the project.

A pharmaceutical factory must have adequate quality-control capability.

Revised Schedule M states that QC laboratories should be separated from production and designed with enough space to avoid mix-ups and cross-contamination.

The exact instruments depend on the products.

A non-sterile formulation laboratory may need equipment such as:

• HPLC
• UV-visible spectrophotometer
• Analytical balances
• pH meter
• Dissolution tester
• Disintegration tester
• Friability tester
• Hardness tester
• Karl Fischer apparatus where required
• Viscometer
• Refractometer
• Stability chambers
• Hot-air oven
• Muffle furnace
• Water-testing equipment

Microbiology Laboratory

Where microbiological testing is required, suitable separate facilities may include:

• Laminar airflow cabinet
• Incubators
• Autoclave
• Colony counter
• Refrigerator
• Microscope
• Sterility-testing arrangement, where applicable
• Microbial-limit-testing facilities

The scope depends strongly on whether the factory produces:

• Non-sterile products
• Sterile products
• Antibiotics
• Biologicals

Quality Assurance Department

Do not budget only for Production and QC.

Modern Schedule M compliance requires a functioning Pharmaceutical Quality System.

QA responsibilities normally include:

• Document control
• Batch-record review
• Line clearance
• Deviations
• CAPA
• Change control
• Validation
• Qualification
• Product Quality Review
• Supplier qualification
• Training
• Self-inspection
• Batch release
• Complaints
• Recall

Revised Schedule M specifically places senior-management responsibility on ensuring that the Pharmaceutical Quality System is adequately resourced.

HVAC System

HVAC is a major investment head.

A pharmaceutical HVAC system may control:

• Temperature
• Relative humidity
• Pressure differentials
• Dust
• Air filtration
• Airflow
• Cross-contamination

Schedule M requires HVAC systems to be appropriately designed, installed and maintained to protect products, personnel and the environment.

Do not calculate HVAC cost simply as the cost of ordinary split air conditioners.

Dust Extraction

Particularly important in:

• Dispensing
• Tablet compression
• Powder processing
• Granulation
• Capsule filling

Systems may include:

• Dust collectors
• Local exhaust
• Vacuum transfer
• Appropriate pressure control

The plant design should prevent dust from moving into adjoining production areas.

Pharmaceutical Water System

The system depends on dosage forms.

Possible grades include:

• Potable water
• Purified Water
• Water for Injection

For oral liquids, revised Schedule M specifically requires defined and routinely monitored Purified Water quality.

For sterile manufacturing, WFI production, storage and distribution require a significantly more sophisticated system.

Other Utilities

A project may need:

• Air compressor
• Clean compressed air
• Boiler
• Pure steam/clean steam where applicable
• Chiller
• Cooling tower
• DG generator
• UPS
• Transformer
• Vacuum system
• Nitrogen
• ETP
• STP
• Fire-safety systems

Do not purchase production machinery before calculating its complete utility requirements.

Warehouse Equipment

Warehouse investment may include:

• Pallet racks
• Storage racks
• Pallets
• Material handling
• Temperature data loggers
• Cold storage/refrigerator
• Quarantine partitions
• Barcode systems
• Sampling booth
• Dispensing booth

Maintain clear status segregation:

Quarantine / Approved / Rejected / Returned / Recalled

Packaging Equipment

Common packaging machinery may include:

• Blister machine
• Strip machine
• Bottle filler
• Capper
• Induction sealer
• Tube filler
• Labeling machine
• Cartoning machine
• Batch coder
• Checkweigher
• Shrink wrapper
• Leak tester

Packing machinery should be selected according to intended commercial pack size and speed.

Technical Manpower

A practical organisation may include:

Production

• Production Head
• Manufacturing chemist
• Production executives
• Supervisors
• Machine operators
• Helpers

Quality Control

• QC Head
• Analytical chemists
• Microbiologists
• Laboratory assistants

Quality Assurance

• QA Head
• IPQA
• Validation personnel
• Documentation staff

Supporting Staff

• Warehouse
• Engineering
• Maintenance
• Regulatory affairs
• Purchase
• HR
• Accounts
• Dispatch
• EHS/Safety

Technical qualifications and experience must satisfy the applicable Drugs Rules and concerned Licensing Authority.

Qualification and Validation

Buying a machine does not make it ready for pharmaceutical production.

Major equipment and systems may require:

Qualification

• Design Qualification
• Installation Qualification
• Operational Qualification
• Performance Qualification

Validation

• Manufacturing-process validation
• Cleaning validation
• Analytical-method validation
• Water-system validation/qualification
• HVAC qualification
• Hold-time studies
• Computer-system validation where applicable
• Sterilization validation for sterile facilities

Schedule M requires equipment to be appropriately located, designed, installed and maintained and requires cleaning procedures to be validated where relevant to contamination and carry-over risk.

Documents Required Before Commercial Production

A compliant plant may require documents including:

• Site Master File
• Quality Manual
• Validation Master Plan
• SOPs
• Master Formula Records
• Batch Manufacturing Records
• Batch Packing Records
• Specifications
• Standard testing procedures
• Cleaning procedures
• Equipment logbooks
• Calibration schedule
• Preventive-maintenance schedule
• Training records
• Supplier qualification
• Deviation procedure
• CAPA procedure
• Change control
• OOS procedure
• Product Quality Review
• Recall procedure

Manufacturing Licence

The appropriate drug manufacturing licence depends on:

• Product category
• Dosage form
• Schedule classification
• Sterile/non-sterile status
• New-drug status
• Biological status

CDSCO maintains the Drugs Rules and current amendments, while manufacture and sale licences for ordinary drug formulations are principally administered through State Licensing Authorities, with central involvement for specified categories and new drugs.

Do not finalize machinery until the product list has been reviewed against the correct licensing route.

Product Permission

Obtaining a manufacturing licence does not automatically permit production of every formulation.

Each commercial product must be appropriately covered by:

• Manufacturing permission
• Approved composition
• Dosage form
• Strength
• Applicable regulatory approvals

New drugs and certain new FDCs may also require approval under the New Drugs and Clinical Trials Rules, 2019.

Capital Investment

There is no reliable universal statement such as:

“A tablet plant costs ₹20 lakh.”

The complete investment depends on:

• Land
• Built-up area
• Product types
• Capacity
• Automation
• HVAC
• Water
• Laboratory
• Packaging
• Utilities
• Validation
• Working capital

A more practical capital-budget structure is:

Investment Head	Typical Planning Importance
Land/building	High
GMP civil work	High
HVAC	High
Production machinery	Very high
Packing machinery	High
QC laboratory	High
Water/utilities	High
Warehouse	Medium
IT/software	Medium
Qualification/validation	Medium-high
Pre-operative expenses	Medium

The actual budget should be prepared from current vendor quotations, not old internet machinery prices.

Obtain Multiple Quotations

For major equipment, obtain at least several comparable quotations covering:

• Capacity
• Material of construction
• Automation
• GMP design
• Utilities
• Electrical load
• Installation
• FAT
• Documentation
• Qualification support
• Warranty
• Spare parts
• Service

The lowest quotation is not automatically the cheapest machine over its operating life.

Working Capital

Working capital may be as important as machinery investment.

You need money for:

• APIs
• Excipients
• Packing material
• Foils
• Cartons
• Bottles
• Salaries
• Electricity
• Testing
• Laboratory consumables
• Freight
• Customer credit
• Rejections
• Stability batches
• Product development

A useful formula is:

Working Capital Requirement = Raw-Material Inventory + Packing Inventory + WIP + Finished Goods + Receivables + Operating Cash − Supplier Credit

Capacity Planning

Never purchase machinery based only on the manufacturer’s advertised maximum output.

Calculate:

Required Annual Output

then consider:

• Batch size
• Changeover
• Cleaning
• Maintenance
• Rejection
• Downtime
• Working shifts

For example, a machine theoretically producing 100,000 tablets per hour will not deliver that output continuously for every working hour of the year.

Capacity Utilisation

For financial planning, use conservative utilisation assumptions during the early years.

An illustrative model might be:

Year	Planning Utilisation
Year 1	25–40%
Year 2	40–55%
Year 3	55–70%

These are business-planning assumptions only, not regulatory standards.

Actual projections should be supported by:

• Existing company sales
• Third-party enquiries
• Letters of intent
• Distributor network
• Export customers

Production Cost

Calculate product cost as:

Raw Material + Packing Material + Direct Labour + Utilities + Testing + Manufacturing Overhead + QA/QC + Depreciation Allocation + Rejection Provision

Then compare against:

• Third-party manufacturing rates
• Market price
• Selling price
• Batch size

A small batch may be technically possible but commercially unprofitable.

Break-Even

Suppose:

Monthly fixed expenses = ₹20 lakh

Contribution margin = 30%

Then:

Break-Even Monthly Sales = ₹20 lakh ÷ 30%

= approximately ₹66.7 lakh

This means machinery should not be justified only by its production capacity.

The project must have enough demand to cover fixed costs.

Major Fixed Expenses

These may include:

• Technical salaries
• QA/QC staff
• Engineering
• Administration
• HVAC
• Maintenance
• Rent
• Interest
• Depreciation
• Security
• Regulatory compliance

Even a factory with no production continues to incur many of these expenses.

Safety Requirements

Production may involve:

• Dust
• Solvents
• Heat
• Pressure
• Chemicals
• Potent APIs
• Moving machinery

Controls should include:

• PPE
• Machine guarding
• Dust extraction
• Chemical storage
• Fire systems
• Emergency exits
• First aid
• Spill response
• Safety training

The applicable occupational-safety framework should be integrated into factory design from the beginning.

Suggested Startup Models

Model A: Tablet + Capsule Unit

Suitable where:

• Market demand is mainly oral solids.
• Third-party manufacturing customers are available.
• Capital is moderate to high.

Major investment:

• RMG
• FBD
• Compression
• Capsule filling
• Blister
• HVAC
• QC

Model B: Liquid + External Preparation Unit

Suitable for:

• Syrups
• Suspensions
• Creams
• Ointments

Major investment:

• Water system
• SS vessels
• Homogenization
• Filling
• Tube filling
• HVAC

Model C: Powder/Capsule Focus

Can offer a more focused starting model where the product portfolio supports it.

Model D: Sterile Injectable Unit

Suitable only with:

• Significantly higher capital
• Sterile-manufacturing expertise
• Strong QA/microbiology
• Confirmed customers

It should be developed as a dedicated project.

Project Implementation Sequence

A practical sequence is:

Phase 1 — Feasibility

• Decide products.
• Estimate market.
• Decide business model.
• Prepare DPR.
• Arrange financing.

Phase 2 — Site

• Select industrial premises.
• Conduct regulatory review.
• Prepare concept layout.

Phase 3 — Engineering

• Finalize GMP layout.
• HVAC design.
• Utility design.
• Water design.
• Electrical design.

Phase 4 — Procurement

• Production machines
• Packing machines
• QC equipment
• Utilities

Phase 5 — Installation

• Civil work
• HVAC
• Water
• Machinery
• Laboratories

Phase 6 — Quality System

• SOPs
• Documentation
• Recruitment
• Training
• Qualification

Phase 7 — Regulatory

• Licence application
• Inspection
• Observation closure
• Product permissions

Phase 8 — Validation

• Process validation
• Cleaning validation
• Analytical validation
• Utility qualification

Phase 9 — Commercial Launch

• Production
• QA release
• Distribution
• Third-party orders
• Own marketing

Common Mistakes

Avoid:

• Purchasing machines before finalizing dosage forms
• Designing from old Schedule M plans
• Treating recommended production-room area as total factory area
• Ignoring HVAC
• Installing only a basic deionizer for pharmaceutical liquids
• Underestimating QC
• Ignoring QA
• Sharing equipment without cleaning validation
• Mixing high-risk products in common facilities
• Starting sterile manufacturing without specialist expertise
• Underestimating working capital
• Assuming machine capacity equals sales
• Buying too much automation before demand exists
• Using outdated equipment prices
• Copying another plant’s layout
• Starting construction without regulatory review

Practical Checklist Before Investment

• Product categories selected
• Dosage forms selected
• Manufacturing licence route checked
• New-drug/FDC status checked
• Market survey completed
• Expected capacity calculated
• Site selected
• GMP layout prepared
• Material flow reviewed
• Personnel flow reviewed
• HVAC designed
• Water system designed
• Utility load calculated
• Machinery list prepared
• Vendor quotations obtained
• QC equipment selected
• Microbiology requirements assessed
• Technical staff planned
• Validation budget included
• Working capital calculated
• Five-year financial projection prepared
• Break-even calculated
• Regulatory consultant/legal review completed where necessary

Final Answer

A pharmaceutical manufacturing project should be planned around the products and GMP system, not merely around machinery.

Revised Schedule M continues to provide recommended machinery and basic installation areas for conventional dosage forms, including tablets, capsules, liquids, external preparations, ophthalmics, powders, inhalers, surgical dressings and parenterals.

However, a modern 2026 factory also requires substantial investment in:

• HVAC
• Pharmaceutical water
• Quality Control
• Quality Assurance
• Validation
• Documentation
• Utilities
• Warehouse controls
• Skilled manpower

Therefore, never estimate total project cost simply by adding the price of a tablet machine, capsule filler and blister machine.

For a new entrepreneur, the safest approach is usually to select one or two commercially strong non-sterile dosage-form sections, build them fully to current GMP requirements and expand after achieving stable quality, sales and capacity utilisation.

Frequently Asked Questions

1. What is the minimum area required for a tablet section?

Revised Schedule M recommends 60 m² for basic installation plus 20 m² ancillary area for uncoated tablets.

2. What is the area for tablet coating?

An additional 30 m² basic plus 10 m² ancillary area is recommended.

3. What is the area for oral liquids?

30 m² basic plus 10 m² ancillary area is recommended.

4. What area is required for capsules?

25 m² basic plus 10 m² ancillary area is recommended.

5. What is the area for external preparations?

30 m² basic plus 10 m² ancillary area is recommended.

6. What is the current basic area recommended for drug repacking?

30 m² under revised Schedule M.

7. How much area is required for injections?

For Small Volume Injectables, Schedule M recommends 150 m² basic plus 100 m² ancillary. For Large Volume Parenterals in the conventional glass-container arrangement, 150 m² basic plus 150 m² ancillary is recommended.

8. Is a QC laboratory compulsory?

A pharmaceutical manufacturing facility requires proper quality-control arrangements. Revised Schedule M requires QC laboratories to be separated from production areas and designed for their testing operations.

9. Can the same machinery be used for different products?

Possibly, where risk assessment supports it and cleaning/changeover controls are validated. Certain high-risk products require dedicated/self-contained arrangements.

10. Is HVAC compulsory?

Environmental control requirements depend on product and process, but revised Schedule M places extensive requirements on appropriate ventilation/HVAC and contamination control.

11. Can I use only DM water for syrup manufacturing?

The liquid-production system should provide and routinely monitor Purified Water meeting applicable requirements.

12. Which is cheaper to start—tablets or injections?

A non-sterile tablet operation is generally simpler than a sterile injectable plant because injectable manufacturing additionally requires classified sterile areas, specialized HVAC, WFI, sterilization, microbiological controls and aseptic-process validation.

13. Should I buy automatic or semi-automatic machinery?

The choice should be based on expected batch size, market demand, manpower cost, product mix and changeover frequency rather than prestige.

14. Can I manufacture tablets, capsules and liquids in one factory?

Yes, subject to appropriate separate sections, layout, HVAC, equipment, licences and contamination-control arrangements.

15. What is the first step before buying machinery?

Finalize the intended products, dosage forms, capacity and regulatory route, then prepare a GMP layout and utility design.

Looking for Ayurvedic Franchise or Distribution Opportunities?

Looking to start an Ayurvedic franchise, become a distributor, or launch your own herbal product range?

Elzac Herbal India offers:

• Ayurvedic & Herbal Product Range
• Franchise & Distribution Opportunities
• Third-Party Manufacturing
• Product Development Support
• Marketing Guidance
• PAN India Business Opportunities

Whether you are an entrepreneur, retailer, distributor, or healthcare professional, our team can help you explore the right business opportunity in the growing Ayurvedic sector.

Contact us today to discuss ayurvedic franchise, distribution, or third-party manufacturing opportunities.